行情

ASMB

ASMB

Assembly生物
NASDAQ

实时行情|Nasdaq Last Sale

20.82
+0.04
+0.19%
交易中 13:58 02/20 EST
开盘
20.82
昨收
20.78
最高
21.01
最低
20.19
成交量
21.28万
成交额
--
52周最高
25.07
52周最低
8.13
市值
6.70亿
市盈率(TTM)
-5.5327
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ASMB 新闻

  • 微软:未来五年将在墨西哥投资11亿美元
  • 新浪美股.3小时前
  • 蔚来汽车涨5.15% 此前传吉利将3亿美元入股蔚来
  • 新浪科技.4小时前
  • 美国汽车贷款增至1.33万亿 投资者需谨慎看待
  • 新浪财经-自媒体综合.4小时前
  • 私募Sycamore Partners以5.25亿美元收购维秘55%股份
  • 新浪美股.4小时前

更多

所属板块

制药
-0.80%
制药与医学研究
-0.71%

热门股票

名称
价格
涨跌幅

ASMB 简况

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein. Its Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal (GI) tract. The lead product candidate from this platform, AB-M101, is in development for the treatment of clostridium difficile-infections.
展开

Webull提供Assembly Biosciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。